Conxita Solans
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Conxita Solans has a total of 318 co-authors. Here are the top co-authors by number of shared publications:
- Jordi Esquena
Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), and Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 08034 Barcelona, Spain
55 shared publications - María José García-Celma
University of Barcelona, Barcelona, Spain
21 shared publications - Carlos Rodríguez-Abreu
IQAC, CSIC, Jordi Girona 18-26, E-08034 Barcelona, Spain; Centro de Investigación Biomédica en Red Bioingeniería, Biomateriales y Nanomedicina, CIBER BBN, ISCIII, Spain
18 shared publications - Gabriela Calderó
Institute of Advanced Chemistry of Catalonia (IQAC-CSIC), C/Jordi Girona, 18-26, Barcelona, Spain; CIBER of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona, Spain
16 shared publications - Ramon Pons
Department of Surfactants and Nanobiotechnology, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), c/Jordi Girona, 18-26, 08034 Barcelona, Spain
15 shared publications - Carmen Gonzalez
Chemical Engineering and Analytical Chemistry Department, Faculty of Chemistry, Universitat de Barcelona, Martí i Franquès, 1, 08028 Barcelona, Spain
14 shared publications
Latest Publications
- 1 August 2019
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 550, 73-80
Formulating stable hexosome dispersions with a technical grade diglycerol-based surfactant
- 1 August 2019
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 550, 73-80
Formulating stable hexosome dispersions with a technical grade diglycerol-based surfactant
- Open Access
- 27 January 2017
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 7 (1) , 2
Methods for the In Vitro Characterization of Nanomedicines—Biological Component Interaction
The design of colloidal nanosystems intended for biomedical applications, specifically in the field of personalized medicine, has increased notably in the last years. Consequently, a variety of characterization techniques devoted to studying nanomedicine interactions with proteins and cells have been developed, since a deep characterization of nanosystems is required before starting preclinical and clinical studies. In this context, this review aims to summarize the main techniques used to assess the interaction of nanomedicines with biological systems, highlighting their advantages and disadvantages. Testing designed nanomaterials with these techniques is required in order to have more information about their behavior on a physiological environment. Moreover, techniques used to study the interaction of nanomedicines with proteins, such as albumin and fibrinogen, are summarized. These interactions are not desired, since they usually are the first signal to the body for the activation of the immune system, which leads to the clearance of the exogenous components. On the other hand, techniques for studying the cell toxicity of nanosystems are also summarized, since this information is required before starting preclinical steps. The translation of knowledge from novel designed nanosystems at a research laboratory scale to real human therapies is usually a limiting or even a final point due to the lack of systematic studies regarding these two aspects: nanoparticle interaction with biological components and nanoparticle cytotoxicity. In conclusion, this review will be a useful support for those scientists aiming to develop nanosystems for nanomedicine purposes.
- 27 January 2017
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 7 (1) , 2
Open AccessMethods for the In Vitro Characterization of Nanomedicines—Biological Component Interaction
The design of colloidal nanosystems intended for biomedical applications, specifically in the field of personalized medicine, has increased notably in the last years. Consequently, a variety of characterization techniques devoted to studying nanomedicine interactions with proteins and cells have been developed, since a deep characterization of nanosystems is required before starting preclinical and clinical studies. In this context, this review aims to summarize the main techniques used to assess the interaction of nanomedicines with biological systems, highlighting their advantages and disadvantages. Testing designed nanomaterials with these techniques is required in order to have more information about their behavior on a physiological environment. Moreover, techniques used to study the interaction of nanomedicines with proteins, such as albumin and fibrinogen, are summarized. These interactions are not desired, since they usually are the first signal to the body for the activation of the immune system, which leads to the clearance of the exogenous components. On the other hand, techniques for studying the cell toxicity of nanosystems are also summarized, since this information is required before starting preclinical steps. The translation of knowledge from novel designed nanosystems at a research laboratory scale to real human therapies is usually a limiting or even a final point due to the lack of systematic studies regarding these two aspects: nanoparticle interaction with biological components and nanoparticle cytotoxicity. In conclusion, this review will be a useful support for those scientists aiming to develop nanosystems for nanomedicine purposes.
- 2 November 2016
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 8 (45) , 31231-31238
From Chromonic Self-Assembly to Hollow Carbon Nanofibers: Efficient Materials in Supercapacitor and Vapor-Sensing Applications
Carbon nanofibers (CNFs) with high surface area (820 m2/g) have been successfully prepared by a nanocasting approach using silica nanofibers obtained from chromonic liquid crystals as a template. CNFs with randomly oriented graphitic layers show outstanding electrochemical supercapacitance performance, exhibiting a specific capacitance of 327 F/g at a scan rate of 5 mV/s with a long life-cycling capability. Approximately 95% capacitance retention is observed after 1000 charge–discharge cycles. Furthermore, about 80% of capacitance is retained at higher scan rates (up to 500 mV/s) and current densities (from 1 to 10 A/g). The high capacitance of CNFs comes from their porous structure, high pore volume, and electrolyte-accessible high surface area. CNFs with ordered graphitic layers were also obtained upon heat treatment at high temperatures (>1500 °C). Although it is expected that these graphitic CNFs have increased electrical conductivity, in the present case, they exhibited lower capacitance values due to a loss in surface area during thermal treatment. High-surface-area CNFs can be used in sensing applications; in particular, they showed selective differential adsorption of volatile organic compounds such as pyridine and toluene. This behavior is attributed to the free diffusion of these volatile aromatic molecules into the pores of CNFs accompanied by interactions with sp2 carbon structures and other chemical groups on the surface of the fibers.
- 2 November 2016
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 8 (45) , 31231-31238
From Chromonic Self-Assembly to Hollow Carbon Nanofibers: Efficient Materials in Supercapacitor and Vapor-Sensing Applications
Carbon nanofibers (CNFs) with high surface area (820 m2/g) have been successfully prepared by a nanocasting approach using silica nanofibers obtained from chromonic liquid crystals as a template. CNFs with randomly oriented graphitic layers show outstanding electrochemical supercapacitance performance, exhibiting a specific capacitance of 327 F/g at a scan rate of 5 mV/s with a long life-cycling capability. Approximately 95% capacitance retention is observed after 1000 charge–discharge cycles. Furthermore, about 80% of capacitance is retained at higher scan rates (up to 500 mV/s) and current densities (from 1 to 10 A/g). The high capacitance of CNFs comes from their porous structure, high pore volume, and electrolyte-accessible high surface area. CNFs with ordered graphitic layers were also obtained upon heat treatment at high temperatures (>1500 °C). Although it is expected that these graphitic CNFs have increased electrical conductivity, in the present case, they exhibited lower capacitance values due to a loss in surface area during thermal treatment. High-surface-area CNFs can be used in sensing applications; in particular, they showed selective differential adsorption of volatile organic compounds such as pyridine and toluene. This behavior is attributed to the free diffusion of these volatile aromatic molecules into the pores of CNFs accompanied by interactions with sp2 carbon structures and other chemical groups on the surface of the fibers.
- 1 May 2015
- Published by Elsevier in Food Chemistry
- Vol. 175, 529-535
Vitamin A Palmitate–β-cyclodextrin inclusion complexes: Characterization, protection and emulsification properties
- 1 May 2015
- Published by Elsevier in Food Chemistry
- Vol. 175, 529-535
Vitamin A Palmitate–β-cyclodextrin inclusion complexes: Characterization, protection and emulsification properties
- Open Access
- 1 January 2015
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 478 (1) , 113-123
Novel non-viral gene delivery systems composed of carbosilane dendron functionalized nanoparticles prepared from nano-emulsions as non-viral carriers for antisense oligonucleotides
- 1 January 2015
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 478 (1) , 113-123
Open AccessNovel non-viral gene delivery systems composed of carbosilane dendron functionalized nanoparticles prepared from nano-emulsions as non-viral carriers for antisense oligonucleotides
- 1 September 2014
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 121, 469-473
Phototherapeutic functionality of biocompatible graphene oxide/dendrimer hybrids
- 1 September 2014
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 121, 469-473
Phototherapeutic functionality of biocompatible graphene oxide/dendrimer hybrids
- 25 August 2014
- Published by Elsevier in Colloids and Surfaces A: Physicochemical and Engineering Aspects
- Vol. 458, 1-2
Editorial
- 25 August 2014
- Published by Elsevier in Colloids and Surfaces A: Physicochemical and Engineering Aspects
- Vol. 458, 1-2
Editorial
- 1 June 2014
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 118, 280-288
Quantifying the bioadhesive properties of surface-modified polyurethane-urea nanoparticles in the vascular network
- 1 June 2014
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 118, 280-288
Quantifying the bioadhesive properties of surface-modified polyurethane-urea nanoparticles in the vascular network